Integrity Advisory’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$761K Sell
6,720
-4,257
-39% -$467K 0.7% 27
2022
Q3
$884K Buy
10,977
+641
+6% +$54.3K 0.82% 24
2022
Q2
$770K Buy
10,336
+4,712
+84% +$430K 0.75% 23
2022
Q1
$719K Buy
+5,624
New +$615K 0.71% 31

Other funds holding DXCM

Integrity Advisory's DXCM Position: Q4 2022 in Review

Integrity Advisory reduced its DexCom (DXCM) stake by 39% in Q4 2022, selling an estimated $467K and leaving 6,720 shares worth $761K. The position accounts for 0.7% of the portfolio, ranked #27.

Integrity Advisory first reported a position in DXCM in Q1 2022 and has held it in 4 quarters since. The position peaked at $884K in Q3 2022. 920 funds tracked by Wall St. Rank hold DXCM as of Q4 2022.

  • Integrity Advisory held 6,720 shares of DexCom worth $761K as of Q4 2022.
  • Integrity Advisory sold 4,257 DexCom shares in Q4 2022, an estimated $467K.
  • DexCom made up 0.7% of Integrity Advisory's portfolio in Q4 2022, its #27 holding.
  • Integrity Advisory first reported a position in DexCom in Q1 2022 and has held it in 4 quarters since.
  • Integrity Advisory's DexCom position peaked at $884K in Q3 2022.
  • 920 funds tracked by Wall St. Rank held DexCom as of Q4 2022.

Based on Integrity Advisory's 13F filing for Q4 2022, filed 24 Jan 2023.